STAT

FEBRUARY 12, 2024

A new study has shown that people vaccinated against Ebola who still developed the disease had a substantially lower risk of dying than people who were not vaccinated, even if they received the vaccine when they were already infected with the virus. It confirms just how major an advancement the Ebola vaccine remains; the study is the first to show that in addition to preventing infections, the vaccine can save some people who are already sick with the often fatal disease.

Vaccines 145

Vaccines 145

Fierce Healthcare

FEBRUARY 12, 2024

As the use of artificial intelligence technology in healthcare grows, federal lawmakers are weighing how to protect patients without hindering innovation and many in Congress are pushing for strong | As the use of artificial intelligence technology in healthcare grows, federal lawmakers are weighing how to protect patients without hindering innovation and many in Congress are pushing for stronger regulation.

145

145

STAT

FEBRUARY 12, 2024

A growing body of data show that South Asians are at greater risk of developing heart disease than white people, and they tend to get complications at younger ages, but it’s not been fully clear what explains this disparity. A new study suggests one potential reason is that South Asians have a decreased ability to repair blood vessels that get injured from cardiovascular problems.

145

145

Pharmacy Times

FEBRUARY 12, 2024

The FDA approval marks the first and only FDA-approved oral therapy for this patient population, and the drug is expected to be available by the end of February.

FDA 145

FDA 145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

FEBRUARY 12, 2024

There was a time when an allegation of data mishandling, scientific misconduct, or just a technical error felt like a crisis to Barrett Rollins, an oncologist and research integrity officer at Dana-Farber Cancer Institute. Now, it’s a Tuesday. The renowned cancer treatment and research center is in the midst of a lengthy review of possible discrepancies involving around 60 papers co-authored by four of its top researchers over a period of over 15 years, including CEO Laurie Glimcher and C

145

145

Pharmacy Times

FEBRUARY 12, 2024

AI can pair people to foods that are best suited for their unique needs, according to a food-as-medicine entrepreneur.

145

145

Pharmacy Times

FEBRUARY 12, 2024

Despite the tool’s ability to predict efficacy of sertraline in patients with major depressive disorder, the investigators note that future research will seek to improve the algorithm.

145

145

Pharmaceutical Technology

FEBRUARY 12, 2024

The UK MHRA has granted approval for a variation in licence of Pfizer-BioNTech’s Comirnaty XBB.1.5 vaccine targeting Omicron variant.

Vaccines 142

Vaccines 142

STAT

FEBRUARY 12, 2024

You’re reading the web version of Health Care Inc.,  STAT’s weekly newsletter  following the flow of money in medicine.  Sign up  to get it in your inbox every Monday.  The FTC doubles down on private equity and Big Physician Dominant physician groups don’t command the same attention as, say, Big Tech firms with national omnipresence like Google and Facebook.

Insurance 138

Insurance Hospitals 138

Fierce Healthcare

FEBRUARY 12, 2024

Providers working in hospitals and critical access hospitals may now text patient information and patient orders among care team members without landing on the wrong side of Medicare’s Conditions o | Texting patient info has been against Medicare's Conditions of Participations for over half a decade, due to concerns of insecure texting platforms.

HIPAA 133

HIPAA Hospitals 133

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 12, 2024

Lina Khan’s Federal Trade Commission is eager to make Big Physician a lot smaller. Last September, the FTC sued private equity firm Welsh, Carson, Anderson & Stowe and U.S. Anesthesia Partners, alleging the two parties conspired to create monopolies for anesthesia services. Both Welsh Carson and USAP have tried to get the case thrown out , but the FTC recently doubled down.

138

138

Pharmacy Times

FEBRUARY 12, 2024

The vitamin improved lipid metabolism to slow the progression of the disease.

132

132

STAT

FEBRUARY 12, 2024

UnitedHealth Group’s Optum has bought an untold number of physician practices over the years. It either owns or is affiliated with over 90,000 providers — almost 10% of all U.S. physicians. That’s mostly happened quietly. But a new Optum purchase in Oregon is getting outsized scrutiny from state regulators — a trend experts say is actually on the rise.

Hospitals 135

Hospitals Insurance 135

Pharmacy Times

FEBRUARY 12, 2024

The updated indication for the respiratory syncytial virus vaccine is for adults aged 50 to 59 with underlying conditions who are at an increased risk of contracting the virus.

Vaccines 132

Vaccines FDA 132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

FEBRUARY 12, 2024

Gilead Sciences said Monday it will acquire CymaBay Therapeutics for $4.3 billion, adding a new treatment for a liver disease that is on track for approval later this year. The deal values CymaBay at $32.50 per share, 27% higher than the stock’s close last Friday. That’s a relatively small takeout premium, but CymaBay shares have doubled in value since last fall on growing investor confidence in the company’s lead drug and speculation that the company could be acquired.

134

134

Fierce Healthcare

FEBRUARY 12, 2024

Kaiser Permanente wrapped up its fiscal year with $329 million of operating income (0.3% operating income), net income of $4.1 billion and more than $100 billion in both operating revenues and expe | The California-based nonprofit noted cost pressures, labor challenges and membership declines but still logged a 0.3% operating income in the wake of 2022's losses.

131

131

STAT

FEBRUARY 12, 2024

On Feb. 5, Buckingham Palace shared the news that King Charles had started treatment for cancer. Although the official statement did not include the particular type of cancer, it closed by noting that, “His Majesty has chosen to share his diagnosis to prevent speculation and in the hope it may assist public understanding for all those around the world who are affected by cancer.

128

128

pharmaphorum

FEBRUARY 12, 2024

Investing in women's health research and funding is not a charity, but a priority. Discover the importance of allocating resources and supporting initiatives that promote women's health and well-being.

127

127

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

FEBRUARY 12, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! Hope your team of choice was victorious in last night’s sports ball match. Today, we talk about psychedelics, obesity, and production issues with generic drugs. We also discuss the ongoing issues of scientific misconduct that are springing up left and right in academia, and how universities are scrambling to keep up.

126

126

pharmaphorum

FEBRUARY 12, 2024

Medicxi has combined six biotechs with dermatology medicines in development in a single drugmaker, called Alys Pharma, which starts life with $100 million in financing.

126

126

Pharmacy Times

FEBRUARY 12, 2024

In addition to improved progression-free survival, patients treated with this regimen also showed improved complete response or stronger and were minimal residual disease-negative.

122

122

Fierce Healthcare

FEBRUARY 12, 2024

The Federal Trade Commission has secured a $195 million judgement against Florida-based insurer Simple Health following allegations that it sold "sham" coverage to consumers. | The Federal Trade Commission has secured a $195 million judgement against Florida-based insurer Simple Health following allegations that it sold "sham" coverage to consumers.

Insurance 122

Insurance 122

Fierce Pharma

FEBRUARY 12, 2024

With a patent feud settled and its approval application back at the FDA’s desk, Sweden’s Xspray Pharma believes it's on track to launch its first commercial product late this summer. | Following a rejection in 2023, the FDA has accepted the resubmission of Xspray’s application for its leukemia candidate Dasynoc, which is seeking to dethrone Bristol Myers Squibb’s entrenched cancer blockbuster Sprycel (dasatinib).

FDA 121

FDA 121

pharmaphorum

FEBRUARY 12, 2024

Study finds that monitoring of rheumatoid arthritis patients with an Apple Watch and iPhone and AI algorithm improves on standard practices.

119

119

Fierce Pharma

FEBRUARY 12, 2024

Eohilia, an oral suspension formulation of the corticosteroid budesonide, has surprisingly won over the FDA even after the drug’s developer, Takeda, had at one point abandoned the program following | Takeda's Eohilia has surprisingly won over the FDA even after the company had at one point abandoned the program following an FDA rejection. But the first FDA-approved oral eosinophilic esophagitis therapy comes with a limitation.

FDA 119

FDA 119

STAT

FEBRUARY 12, 2024

While staffing crises at hospitals continue to make headlines, dental care — too often overlooked and treated as separate from medical — is also experiencing a significant workforce challenge. In my role leading dental at Sun Life U.S., which includes DentaQuest, the nation’s largest Medicaid dental benefits organization, I know full well that you cannot be healthy without a healthy mouth.

Hospitals 115

Hospitals 115

Fierce Pharma

FEBRUARY 12, 2024

After a series of regulatory setbacks in Europe, PTC Therapeutics will soon find itself under a generic attack in the U.S. | After a series of regulatory setbacks in Europe, PTC Therapeutics will soon find itself under a generic attack in the U.S.

FDA 116

FDA 116

pharmaphorum

FEBRUARY 12, 2024

GSK’s antisense-based drug for chronic hepatitis B, bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval

FDA 115

FDA 115

Fierce Healthcare

FEBRUARY 12, 2024

An “overwhelming” 88% of respondents reporting healthcare discrimination in a new screening initiative were Black, according to a new Humana study. | An “overwhelming” 88% of respondents reporting healthcare discrimination in a new screening initiative were Black, according to a new Humana study.

115

115

Drug Topics

FEBRUARY 12, 2024

The NDA submitted by Lykos Therapeutics was assigned a Prescription Drug User Fee Act date of August 11, 2024.

FDA 112

FDA 112

Drug Store News

FEBRUARY 12, 2024

Ryan will speak at the Chain Members and Political Action Committee Breakfast.

111

111

pharmaphorum

FEBRUARY 12, 2024

Changing Faces: Agency, consultancy, and investor hires from January 2024 highlights the recent hires and movements in prominent companies such as Permira, Cuttsy+Cuttsy, SV Health Investors, and Cure Ventures. Stay updated with the latest talent appointments in the industry.

111

111

STAT

FEBRUARY 12, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of online meetings, phone calls, and deadlines has returned. But what can you do? The world, such as it is, continues to spin at a brisk pace. So time to give it a nudge in a better direction with a cup or three of stimulation.

Vaccines 107

Vaccines Communication Hospitals 107